ClinicalTrials.gg
Drug

Eflornithine clinical trials

Also written DFMO, Vaniqa and IWILFIN.

studies test it
43
open now
9
in phase 3
8
first study started
1995

How each study uses Eflornithine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Eflornithine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Nov 1990 · ORNIDYL · NDA 019879 (FDA, Drugs@FDA)
European Union
19 Mar 2001 · Vaniqa · EMEA/H/C/000325 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Eflornithine
22
Difluoromethylornithine
16
Difluromethylornithine
5
Alpha-Difluoromethylornithine
3
Difluoromethylornithine (DFMO)
2

Brand

Vaniqa
2
IWILFIN
2

Other names

DFMO
21

In one entry with another drug

Given together, or one or the other

Eflornithine plus sulindac
2

Studies by the year they started

41 studies that test it; most in 2023 (6)

Studies that test Eflornithine, by start year
YearStudies
19951
19983
19991
20013
20031
20041
20071
20091
20101
20111
20121
20132
20143
20152
20163
20191
20201
20212
20236
20241
20251
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
28
Phase 3
8
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 36

Giselle Sholler (7) · National Cancer Institute (NCI) (4) · Cancer Prevention Pharmaceuticals, Inc. (3) · National Skin Centre (2) · University of Alabama at Birmingham (2) · University of Wisconsin, Madison (2) · University of Arizona (2) · Mayo Clinic (2)

Often tested with

Tested in the same studies.

Sulindac (5) · Diclofenac (2) · Diclofenac Sodium Gel (2) · AMXT-1501 dicaprate (2) · Tretinoin (1) · Hydroquinone (1) · Celecoxib (1) · Cyclophosphamide (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Eflornithine, phase 3 first.

Studies

Open first, then newest update. How each study uses Eflornithine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 43

See all 43 studies that test Eflornithine →

Given beside what is tested · 4 — Eflornithine is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Eflornithine

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Eflornithine · ClinicalTrials.gg INT006930

  • MeSH (NLM) D000518EflornithineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) ZQN1G5V6SREFLORNITHINEConfirmed FDA, NLM, Wikidata
  • RxNorm 569Confirmed FDA, Wikidata
  • Wikidata Q424751(RS)-eflornithineConfirmed FDA, NLM, Wikidata
  • Wikidata Q72470623EflornithineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C226EflornithineOne source FDA
  • DrugBank DB06243One source Wikidata

Also registered as eflornithine hydrochloride (UNII 4NH22NDW9H · RxNorm 81945).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.